ARCTURUS THERAPEUTICS HOLDINGS INC.

(ARCT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 1651 122976453--
Enterprise Value (EV)1 165673668366389391
P/E ratio -5,06x-12,2x-4,78x-2,48x-15,6x4,57x
Yield ------
Capitalization / Revenue 7,92x118x78,9x14,4x2,15x1,18x
EV / Revenue 7,92x70,5x54,1x11,7x1,85x1,02x
EV / EBITDA ---3,31x-1,64x-1,65x-1,71x
Price to Book ------
Nbr of stocks (in thousands) 15 13825 85826 36126 419--
Reference price (USD) 10,943,437,017,117,117,1
Announcement Date 03/11/202003/01/202102/28/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 20,89,5412,431,3211384
EBITDA1 ---202-222-236-229
Operating profit (EBIT)1 -25,5-71,5-203-189-41,1116
Operating Margin -123%-750%-1 641%-604%-19,5%30,2%
Pre-Tax Profit (EBT)1 -26,0-72,1-204-187-56,4-32,8
Net income1 -26,0-72,1-204-190-35,1115
Net margin -125%-756%-1 648%-605%-16,7%30,0%
EPS2 -2,15-3,55-7,74-6,90-1,103,75
Dividend per Share2 ------
Announcement Date 03/11/202003/01/202102/28/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 2,445,795,242,837,7016,9
EBITDA ------
Operating profit (EBIT)1 -53,8-37,6-50,4-48,9-46,7-41,5
Operating Margin -2 208%-650%-961%-1 725%-606%-246%
Pre-Tax Profit (EBT)1 -54,1-38,7-51,2-50,5-46,5-38,7
Net income1 -54,1-38,7-51,2-49,7-47,8-42,1
Net margin -2 219%-667%-976%-1 754%-621%-249%
EPS2 -2,05-1,47-1,94-1,90-1,70-1,41
Dividend per Share ------
Announcement Date 11/08/202102/28/202205/09/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 -44930787,064,061,9
Leverage (Debt / EBITDA) --1,52x0,39x0,27x0,27x
Free Cash Flow1 --44,6-236-13470,5158
ROE (Net Profit / Equities) ---65,2%-157%-350%-140%
Shareholders' equity1 --31212110,0-82,1
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 0,821,74-4,006,186,30
Capex / Sales 3,93%18,3%-12,8%2,93%1,64%
Announcement Date 03/11/202003/01/202102/28/2022---
1 USD in Million
Previous periodNext period
Estimates
Key data
Capitalization (USD) 452 556 870
Net sales (USD) 12 359 000
Number of employees 177
Sales / Employee (USD) 69 825
Free-Float 86,1%
Free-Float capitalization (USD) 389 757 177
Avg. Exchange 20 sessions (USD) 11 835 052
Average Daily Capital Traded 2,62%
EPS & Dividend